
It was the aim of the review to determine the risks and benefits of primary zzso with zzso in cancer patients with central zzso zzso zzso Central and Google Scholar databases were searched for zzso controlled trials zzso in June zzso Two zzso extracted data and zzso the quality of zzso zzso were expressed as relative risk zzso with zzso confidence intervals zzso using random effects model for the outcomes of zzso zzso bleeding and zzso Eight zzso zzso zzso were zzso There was no statistically significant difference in the risk of zzso zzso for the use of zzso versus zzso (3 trials, 425 patients, zzso zzso zzso zzso zzso p zzso zzso zzso versus zzso (4 trials, zzso patients, zzso zzso zzso zzso zzso p zzso zzso or zzso zzso zzso or zzso zzso versus zzso (7 trials, zzso patients, zzso zzso zzso zzso zzso p zzso zzso zzso statistical zzso was noted among these trials zzso zzso zzso The use of zzso showed no statistically significant difference in the risk of overall bleeding (5 trials, zzso patients, zzso zzso zzso zzso zzso p zzso zzso and zzso for zzso versus zzso (4 trials, zzso patients, zzso zzso zzso zzso zzso zzso p zzso zzso without any statistical zzso zzso zzso zzso In cancer patients with central zzso devices, zzso has no significant effect on the risk of zzso related zzso or zzso The use of primary zzso in cancer patients with central zzso zzso while not causing any harm provides no zzso 

